CAS号:1000413-72-8
品名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]aceticacid
中文别名:(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸
英文别名:Fasiglifam(INN);Fasiglifam;3-Benzofuranaceticacid,6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-,(3S);TAK-875;((3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl)aceticacid;
分子式:C29H32O7S
分子量:524.625
精确质量:524.187
Psa:107.51
MDL号:MFCD18251445
密度:1.3±0.1g/cm3
沸点:739.1±60.0°Cat760mmHg
闪点:400.8±32.9°C
折射率:1.587
储存条件:2-8℃
蒸汽压:0.0±2.6mmHgat25°C
简介:TAK-876isaselectiveGprotein-coupledreceptor40(GPR40)agonist.TAK-876isanoveloralmedicationthathasbeendevelopedtoimprovethesecretionofinsulininaglucose-dependentmanner,whichhasthepotentialtoimprovethecontrolofbloodsugarlevelswithouttheriskofhypoglycemia.
G蛋白偶联受体&G蛋白